Many team members at Unicorn Nest are Ukrainians affected by Russian aggression. We do our best to solve any issues and answer your questions in the shortest possible time frames but some delays are possible.

Top 20 investors in North Africa and the Middle East that took part in the most funding rounds in Biotechnology industry over the recent years

Top 20 investors in North Africa and the Middle East that took part in the most funding rounds in Biotechnology industry over the recent years

Intro

The top 20 investors according to the total amount of funding rounds. These are VC funds and corporate investors in North Africa and the Middle East that have invested over the last 3 years. They are actively investing in Biotechnology industry.
Biotechnology is the use of biology to make or develop products. It includes biopharmaceutical, genetics, and neuroscience.

Amount of funding rounds in North Africa and the Middle East is 123, which is 1.5% of the total amount of rounds in the Biotechnology industry over the last 3 years.

Top 20 investors in North Africa and the Middle East that took part in the most funding rounds in Biotechnology industry over the recent years
data provided by Unicorn Nest

Save this chart to use it in your presentation
Download the diagram

Key takeaways

  • Funds Geography – The most common country among top VCs is Israel which hosts 14 funds. There are also funds from Turkey, United Arab Emirates and Qatar. The most common city is Tel Aviv which is home to 11 funds. There are also funds from Istanbul, Or Yehuda and Misgav. VCs in the sample usually invest in The United States and Israel. They also invest in Turkey and Egypt. For the majority of the funds, the country of the funds’ establishment and the country of their most frequent investments coincide.
  • Industry Focus – The funds’ most common field for investments is Finance. They also invest in Medical Service, Gamification and Social.
  • Important Years – The oldest fund in the sample was founded in 1993 and the newest one in 2018. In 2015 the most amount of funds were founded. VCs in the sample made the most deals in the period from 2000 to 2021. For some funds, 2020 was the year with the most amount of deals. The biggest amount of successful exits happened between 2011 and 2021 years. For some funds, 2016 became the year with the most successful exits.
  • Investments – Usually VCs take part in 2 funding rounds per year, sometimes in 2 – 6. The minimum number of funding rounds for VCs in the sample is 5, the maximum is 297. Average number of funding rounds is 46.4 while median is 36.5. The most common amount of funding rounds for VCs in the sample is 5. Minimum amount of lead investments for funds is 0 and maximum is 56. Average amount of lead investments is 7.4 while median is 3.5. The most common amount of lead investments is 2. Index of difference in percentage points of lead investments from the average is between -71.0 and 29.0 for funds in the sample. The average value for this difference is 5.8 and the median is 8.71. It means that these funds act as lead investors more often than other funds. The most common value is 0.43.
  • Typical Rounds – The most common investment stage for funds in the sample is Early stage. Seed, Late and Private Equity stages are less common. Funding rounds with these VCs have 4 – 5 or 1 – 2 investors. VCs in the sample have an average round size of 100 thousands – 1 million or 10 – 50 million. A Funds’ average multiplicator for portfolio companies at the last known valuation is close to zero at minimum and 14.85 at maximum. Average value for this multiplicator is 3.02 and median is 0.93. The most common multiplicator value is close to zero.
Biotechnology North Africa and the Middle East
Looking for investments?
We help you to get a list of investors based on your personal choice
Crunchbase icon

Content report

The following text will be sent to our editors: